ⓘ Lirilumab

                                     

ⓘ Lirilumab

Lirilumab is a human monoclonal antibody designed for the treatment of cancer. It binds to KIR2DL1/2L3.

This drug is developed by innate Pharma and is licensed to Bristol-Myers Squibb.